Generation of a transgenic mouse for colorectal cancer research with intestinal cre expression limited to the large intestine.
Generation of a transgenic mouse for colorectal cancer research with intestinal cre expression limited to the large intestine.
复制标题
DOI：
10.1158/1541-7786.mcr-10-0195
复制
发表时间：
2010-08
期刊：
影响因子：
--
通讯作者：
Fleet JC
中科院分区：
文献类型：
--
作者：
Xue Y;Johnson R;Desmet M;Snyder PW;Fleet JC
Genetically modified mice have been used for colon cancer research but findings from these models are confounded by expression of cancer in multiple organs. We sought to create a transgenic mouse with Cre recombinase (Cre) expression limited to the epithelial cells of the large intestine and use this model to study colon cancer driven by adenomatosis polyposis coli (APC) gene inactivation. A promoter/enhancer from the mouse carbonic anhydrase I gene was used to generate a Cre expressing transgenic mouse (CAC). After characterizing transgene expression and distribution, CAC mice were crossed to APC580S mice to generate mice with APC inactivation at one (CAC; APC580S/+) or both alleles (CAC; APC580S/580S). Transgene expression was limited to the epithelial cells of the cecum and colon, extended from the crypt base to the luminal surface, and was expressed in approximately 15% of the crypts. No abnormal gross phenotype was seen in 3 or 6 wk CAC; APC580S/+ mice but CAC; APC580S/580S mice had significant mucosal hyperplasia in the colon at 3 wk that developed into tumors by 6 wk. By 10 wk, 20% of CAC; APC580S/+ mice developed adenomatous lesions in the distal colon (3.0±0.4 mm, 1.1 per mouse). Dextran sulfate sodium treatment increased the incidence and number of tumors and this occurred predominantly in distal colon. Our new model has improved features for colon cancer research i.e. transgene expression is limited to the epithelium of the large bowel with normal cells found next to genetically modified cells.
